Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
504.50    -0.50 (-0.10%)
Bid:
502.00
Ask:
503.00
Spread: 1.00 (0.199%)
Market Cap: £2.23b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director Declaration

30 Aug 2019 12:00

RNS Number : 7215K
Tate & Lyle PLC
30 August 2019
 

Tate & Lyle PLC

 

 

Notification of change in Director's details 

 

Dr Ajai Puri, Non-Executive Director of Tate & Lyle PLC, has been appointed to the Board of Olam International Limited, a company listed on the Singapore stock exchange, as a Non-Executive Director, effective 1 September 2019.

 

This disclosure is made in accordance with Listing Rule 9.6.14.

 

Claire-Marie O'Grady

Company Secretary

 

30 August 2019

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RDNKBLBXKVFEBBD
Date   Source Headline
22nd May 202612:26 pmRNSForm 8.3 - Tate & Lyle plc
22nd May 202612:11 pmRNSForm 8.5 (EPT/RI)-Tate & Lyle PLC
22nd May 202611:24 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
22nd May 202611:14 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
22nd May 202611:03 amRNSForm 8.3 TATE & LYLE PLC
22nd May 202610:53 amRNS20260521_TATE & LYLE_8.5 EPT RI_UK_MLI
22nd May 202610:47 amRNS20260521_TATE & LYLE_8.5 EPT NON-RI_UK_BOFASE
22nd May 20269:19 amRNSForm 8.3 Tate & Lyle PLC
22nd May 20269:01 amRNSForm 8.5 (EPT/RI)
22nd May 20268:29 amRNSForm 8.3 - Tate & Lyle PLC
21st May 20264:20 pmRNSForm 8.3 Tate & Lyle PLC
21st May 20263:56 pmRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
21st May 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
21st May 20263:08 pmRNSForm 8.3 Tate & Lyle plc
21st May 20262:27 pmRNSForm 8.3 - Tate & Lyle plc
21st May 20261:55 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
21st May 20261:42 pmRNSForm 8.5 - Tate & Lyle Plc
21st May 20261:27 pmRNSForm 8.5 (EPT/NON-RI) - Tate and Lyle PLC
21st May 20261:23 pmRNSForm 8.3 Tate & Lyle PLC
21st May 202612:15 pmRNSForm 8.3 - Tate & Lyle plc
21st May 202612:06 pmBUSForm 8.3 - Tate & Lyle
21st May 202611:53 amRNSForm 8.5 (EPT/RI) - Tate & Lyle PLC
21st May 202611:22 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
21st May 202611:13 amRNS20260520_TATE & LYLE_8.5 EPT NON-RI_UK_BOFASE
21st May 202611:11 amRNS20260520_TATE & LYLE_8.5 EPT RI_UK_MLI
21st May 202611:09 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
21st May 202611:01 amRNSForm 8.3 TATE & LYLE PLC
21st May 202610:28 amRNSForm 8.3 - Tate & Lyle Plc
21st May 20268:29 amRNSForm 8.5 (EPT/RI)
21st May 20267:00 amRNSFinal Results
20th May 20264:28 pmRNSForm 8.5 - Tate & Lyle Plc
20th May 20264:26 pmRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
20th May 20263:27 pmRNSForm 8.3 Tate & Lyle plc
20th May 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
20th May 20262:49 pmRNSForm 8.3 - Tate & Lyle plc
20th May 20262:03 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
20th May 20261:52 pmRNSForm 8.3 - Tate & Lyle plc
20th May 20261:28 pmRNSForm 8.3 - Tate & Lyle plc
20th May 20261:22 pmRNSForm 8.3 TATE & LYLE PLC
20th May 202612:26 pmRNSForm 8.3 Tate & Lyle Plc
20th May 202612:05 pmRNSForm 8.3 - Tate & Lyle plc
20th May 202611:59 amRNSForm 8.5 (EPT/NON-RI) - Tate & Lyle PLC
20th May 202611:58 amRNSForm 8.5 (EPT/RI) - Tate & Lyle PLC
20th May 202611:47 amRNSForm 8.3- TATE & LYLZ
20th May 202611:35 amRNS20260519_TATE & LYLE_8.5 EPT RI_UK_MLI
20th May 202611:15 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle Plc
20th May 202611:02 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
20th May 20269:21 amRNSForm 8.5 (EPT/RI)
20th May 20269:18 amRNSForm 8.3 - Tate and Lyle PLC
20th May 20267:33 amRNSForm 8.5 (EPT/RI) - Amend - Tate & Lyle PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.